SCHEMBL6943633

SCHEMBL6943633

COCCNS(=O)(=O)c1ccc2c(c1)C(Cl)(Cl)C(=O)N2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
PKM P14618 4/20 0.58
TSHR P16473 2/20 0.58
POLB P06746 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
PKLR P30613 1/20 0.55
LMNA P02545 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HPGD P15428 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
MAPT P10636 1/20 0.54
RAB9A P51151 1/20 0.54
GAA P10253 2/20 0.52
HTT P42858 4/20 0.49
ALOX15 P16050 1/20 0.49
PNMT P11086 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947428 0.86 PKLR (0.52) ALDH1A1PKMTSHRPOLBMEN1
SCHEMBL14111831 0.78 ALDH1A1 (0.67) ALDH1A1PKMTSHRPOLBMEN1
SCHEMBL8307133 0.78 CASP3 (0.63) ALDH1A1PKLRLMNAMAPTGAA
SCHEMBL6949092 0.75 HTR2C (0.54) ALDH1A1MEN1KMT2APKLRLMNA
SCHEMBL6951305 0.75 MGAT2 (0.60) ALDH1A1PKMPOLBPKLRLMNA
SCHEMBL20202312 0.74 ALDH1A1 (1.00) ALDH1A1PKMTSHRPOLBMEN1
SCHEMBL13159473 0.74 ALDH1A1 (0.94) ALDH1A1PKMTSHRPOLBMEN1
SCHEMBL6946099 0.73 TBXAS1 (0.49) POLBPKLRKDM4EGAAIDO1
SCHEMBL6954051 0.73 PKLR (0.55) ALDH1A1POLBMEN1KMT2APKLR
SCHEMBL8413770 0.72 ALDH1A1 (0.62) ALDH1A1PKMTSHRPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP claimed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US claimed
EP-0988035-B1 CASPASES AND APOPTOSIS SMITHKLINE BEECHAM CORP (US) 2003-05-02 EP disclosed
US-6214858-B1 PREVENTING AND TREATING EXCESSIVE CELL DEATH USING OXINDOLE DERIVATIVES SMITHKLINE BEECHAM CORPORATION 2001-04-10 US disclosed